Completed

NCT Number: NCT01768078

Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis

One useful effect of early intravitreal corticotherapy is to diminish inflammatory complications after endophthalmitis, which may cause, at least in part, serious complications (retinal detachment, macular edema) which are, more than the infection, causes of the complications seen after acute endophthalmitis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post-operative Endophthalmitis

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

CHU de Besançon, Besançon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients male or female with no age limit
Hospitalized for the diagnosis and treatment of acute endophthalmitis following cataract surgery
Who had given their consent after being informed about intravitreal corticotherapy

Exclusion criteria

Patients who refused or were unable to give their consent
Prior intravitreal corticotherapy

Treatment and study plan

Intravitreal injection of Betamethasone + antibiotics

Procedure

Intravitreal injection of antibiotics

Procedure

Primary outcomes

Measure the evolution of visual acuity

Time frame: up to12 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Official study title

Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.

Acronym: Endophtalmitis

Important dates

Study start: 2008
Primary completion: 2014
Study completion: 2014
First posted: Jan 15, 2013
Registry last updated: Dec 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.